Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarlowe Regulatory News (MRL)

  • This share is currently suspended. It was suspended at a price of 440.00
  • There is currently no data for MRL

Holding(s) in Company

8 Jul 2025 14:02

RNS Number : 2190Q
Marlowe PLC
08 July 2025
Ā 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BD8SLV43

Issuer Name

MARLOWE PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

JPMorgan Chase & Co.

City of registered office (if applicable)

Ā 

Country of registered office (if applicable)

US

4. Details of the shareholder

Name

City of registered office

Country of registered office

J.P. Morgan Securities plc

5. Date on which the threshold was crossed or reached

04-Jul-2025

6. Date on which Issuer notified

08-Jul-2025

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

5.116380

0.000000

5.116380

4017516

Position of previous notification (if applicable)

4.988984

0.000000

4.988984

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BD8SLV43

4017516

5.116380

Sub Total 8.A

4017516

5.116380%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

Ā 

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Ā 

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

JPMorgan Chase & Co.

J.P. Morgan Securities plc

5.024241

5.024241%

JPMorgan Chase & Co.

J.P. Morgan SE

10. In case of proxy voting

Name of the proxy holder

Ā 

The number and % of voting rights held

Ā 

The date until which the voting rights will be held

Ā 

11. Additional Information

Chain of controlled undertakings:JPMorgan Chase & Co.JPMorgan Chase Bank, National Association (100%)J.P. Morgan International Finance Limited (100%)J.P. Morgan Capital Holdings Limited (100%)J.P. Morgan Securities plc (100%)JPMorgan Chase & Co.JPMorgan Chase Bank, National Association (100%)J.P. Morgan International Finance Limited (100%)J.P. Morgan SE (100%)

12. Date of Completion

08-Jul-2025

13. Place Of Completion

London

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Ā 
END
Ā 
Ā 
HOLPKFBKNBKDKOK
Date   Source Headline
5th Aug 20257:00 amRNSCancellation - Marlowe Plc
4th Aug 20253:55 pmRNSForm 8.5 (EPT/RI) -Amendment - Marlowe PLC
4th Aug 20253:53 pmRNSForm 8.5 (EPT/RI) -Amendment - Marlowe PLC
4th Aug 20253:25 pmRNSForm 8.3 - Marlowe plc
4th Aug 20252:58 pmRNSForm 8.3 - Marlowe plc
4th Aug 20252:47 pmRNSForm 8.3 - Mitie Group plc
4th Aug 20252:27 pmRNSForm 8.3 MARLOWE PLC
4th Aug 20251:56 pmRNSForm 8.3 - MARLOWE PLC
4th Aug 20251:14 pmRNSForm 8.3 - Marlowe plc
4th Aug 202512:07 pmBUSForm 8.3 - Marlowe PLC
4th Aug 202512:00 pmRNSForm 8.5 (EPT/RI) Marlowe Plc
4th Aug 202511:45 amRNSMitie completes the Acquisition of Marlowe plc
4th Aug 202511:26 amRNSForm 8.3 - Marlowe PLC
4th Aug 20259:30 amRNSHolding(s) in Company
4th Aug 20257:30 amRNSSuspension - Marlowe plc
1st Aug 20253:20 pmRNSForm 8.3 - Mitie Group Plc
1st Aug 20251:57 pmRNSForm 8.3 - Mitie Group plc
1st Aug 20251:09 pmRNSForm 8.3 MARLOWE PLC
1st Aug 202512:32 pmBUSForm 8.3 - Marlowe PLC
1st Aug 202512:19 pmPRNForm 8.3 - Marlowe Plc
1st Aug 202511:54 amRNSForm 8.5 (EPT/RI) - Marlowe PLC
1st Aug 20258:52 amRNSHolding(s) in Company
31st Jul 20253:25 pmBUSForm 8.3 - Marlowe plc
31st Jul 20253:25 pmRNSForm 8.3 - Marlowe plc
31st Jul 20253:12 pmBUSForm 8.3 - Marlowe PLC
31st Jul 20253:06 pmRNSForm 8.3 MARLOWE PLC
31st Jul 20252:18 pmRNSForm 8.3 - Mitie Group Plc
31st Jul 202512:49 pmRNSCourt Sanction of Scheme
31st Jul 202512:48 pmRNSForm 8.3 - Marlowe plc
31st Jul 202512:00 pmRNSForm 8.5 (EPT/RI) Marlowe Plc
30th Jul 20256:04 pmRNSHolding(s) in Company
30th Jul 20256:03 pmRNSHolding(s) in Company
30th Jul 20253:25 pmRNSForm 8.3 - Marlowe plc
30th Jul 20252:44 pmRNSForm 8.3 - Mitie Group plc
30th Jul 20252:30 pmGNWForm 8.3 - [MARLOWE PLC - 29 07 2025] - (CGWL)
30th Jul 20251:36 pmRNSForm 8.3 MARLOWE PLC
30th Jul 202512:47 pmRNSForm 8.3 - Marlowe plc
30th Jul 202512:00 pmRNSForm 8.5 (EPT/RI) Marlowe Plc
30th Jul 202512:00 pmRNSForm 8.5 (EPT/RI) - Marlowe Plc
30th Jul 202511:47 amRNSForm 8.5 (EPT/RI) - Marlowe PLC
30th Jul 202511:42 amRNSForm 8.3 - Mitie Group Plc
30th Jul 202511:24 amRNSForm 8.3 - Marlowe PLC
29th Jul 20253:25 pmRNSForm 8.3 - Marlowe plc
29th Jul 20253:13 pmRNSForm 8.3 MARLOWE PLC
29th Jul 20252:38 pmGNWForm 8.3 - [MARLOWE PLC - 28 07 2025] - (CGWL)
29th Jul 20252:15 pmBUSForm 8.3 - Marlowe PLC
29th Jul 202512:31 pmRNSForm 8.3 - Marlowe PLC
29th Jul 202512:09 pmRNSForm 8.5 (EPT/RI) - Marlowe PLC
29th Jul 202512:09 pmRNSForm 8.3 - Marlowe plc
29th Jul 202512:00 pmRNSForm 8.5 (EPT/RI) - Marlowe Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.